Here are some bonus material in the meantime people, please enjoy!
For years I've been advocating, using tamoxifen with Nandrolone.
Deca gyno and how to stop it?
Contrary to popular belief, progesterone blockers are not effective in preventing gynecomastia caused by nandrolone decanoate. However,
Euro-Pharmacies Tamoxifen is a game-changer in this scenario. Let's put an end to the misconception that Tamoxifen should never be used with a 19-nor compound like deca.
Debunking the myth were people say never use Tamoxifen with a 19-nor, like deca.
Progesterone blockers are not effective in preventing gynecomastia caused by nandrolone decanoate. However, Euro-Pharmacies Tamoxifen has been shown to be effective in combating this issue.
There is a common misconception that Tamoxifen should never be used with 19-nor compounds like deca. However, research has shown that Euro-Pharmacies Tamoxifen can indeed be beneficial in these cases.
Studies conducted by Theramex, a pharmaceutical company, have demonstrated that the progesterone blocker RU486 is not effective in treating gynecomastia caused by nandrolone decanoate or other 19-nor-androgens.
It is important to note that nandrolone decanoate converts to estradiol five times more difficultly than testosterone. This information has been known since the 1950s, when researchers conducted test tube studies. In fact, nandrolone is considered a 19-nor-testosterone compound.
In conclusion, while progesterone blockers may not be effective in preventing gynecomastia caused by nandrolone decanoate,
Euro-Pharmacies Tamoxifen has shown promise in addressing this issue. It is crucial to consider all available research and consult with a healthcare professional before making any decisions regarding steroid use.
Doping experts are well aware that certain steroids, like deca, can still lead to gynecomastia despite being less prone to converting into estradiol compared to testosterone. This phenomenon is often attributed to the progestagen-like effects of these drugs. These steroids can bind to progesterone receptors, mimicking the actions of progesterone in the body. This suggests that progesterone-like steroids may have similar effects on men as progesterone does on women.
The proposed solution to combat this issue is the use of
anti-progestagens such as RU486, which is currently the most potent progesterone blocker available. However, research conducted by Théramex revealed that progesterone blockers are ineffective in preventing gynecomastia caused by 19-nor-androgens.
In a study published in 1995, researchers examined the estrogenic effects of various progestagens, including derivatives of 19-nor-testosterone. The results of this study, summarized in the table below, show the estrogenic effects of 19-norT (nandrolone) and its relatives (NEL, NGM, LNG, NETA) at different concentrations compared to estradiol. The table provides a clear comparison of the estrogenic effects of these compounds, with estradiol set as the standard at 100.
Overall, understanding the complex interactions between steroids and hormones is crucial in developing effective strategies to mitigate the side effects associated with steroid use.
Exciting news! Researchers have discovered that all androgens within the progestagens have an estrogenic effect, with some even surpassing that of estradiol at extremely high concentrations. These findings were uncovered through tests conducted on cells in a test tube, where researchers measured the production of an enzyme that was stimulated by the estrogen receptor.
Curiosity piqued, the researchers delved deeper into what caused this estrogenic effect. Could it be related to the progesterone effect of the 19-nor drugs? To investigate, they repeated the tests while introducing the RU486 progesterone blocker and the anti-estrogen 4-hydroxy tamoxifen into the test tubes. The results were fascinating, as shown in the figure below, especially when the 19-nor-androgen norethindrone was used.
These groundbreaking findings shed light on the complex interactions between androgens and progestagens, opening up new avenues for further research and exploration in the field. Stay tuned for more exciting developments in this fascinating area of study!
Upon closer examination, it is evident that the addition of the progesterone blocker did not impact the production of the enzyme. This suggests that progesterone activity is not linked to the estrogenic effect of 19-nor-androgens. Conversely, the introduction of the anti-estrogen did result in a reduction in enzyme production.
In further experimentation, researchers administered aminoglutethimide, a substance known for its ability to completely halt aromatase activity. Surprisingly, this had no effect on the enzyme production. Therefore, it can be concluded that the estradiol effect is not influenced by aromatase.
Through meticulous testing and analysis, we have gained valuable insights into the intricate interactions between hormones and enzymes. These findings shed light on the complex mechanisms at play within the body, paving the way for further exploration and discovery in the field of endocrinology.
What exactly triggers the estrogenic effect? Well, that's the million-dollar question. The researchers are still scratching their heads over it. Back in 1995, they threw out the idea that it might be some mysterious byproducts of the androgens. Fast forward to 2003, and now they're entertaining the notion that
19-nor-androgens could be masquerading as estrogens.
So, what's the bottom line for all you athletes out there? It's crystal clear - Anti-Prostegans won't do squat against Gyno caused by Deca. Your best bet? Reach for the antiestrogens (SERMS) like Euro-Pharmacies tamoxifen. Trust me, it's the way to go.
Euro-Pharmacies Tamoxifen for the win!
There is a plethora of other sponsors on here that have some phenomenal products that have tested far above expectancy, exceeding everyone's expectations.
Whatever course of action you take, It would not hurt having tamoxifen on hand.